網膜色素変性症治療の世界市場（～2026年）

• 英文タイトル：Global Retinitis Pigmentosa Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04504
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、129ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は網膜色素変性症治療のグローバル市場について調査・分析したレポートです。種類別（BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他）市場規模、用途別（病院、クリニック、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別網膜色素変性症治療の競争状況、市場シェア
・世界の網膜色素変性症治療市場：種類別市場規模 2015年-2020年（BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他）
・世界の網膜色素変性症治療市場：種類別市場規模予測 2021年-2026年（BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他）
・世界の網膜色素変性症治療市場：用途別市場規模 2015年-2020年（病院、クリニック、在宅医療）
・世界の網膜色素変性症治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、在宅医療）
・北米の網膜色素変性症治療市場分析：米国、カナダ
・ヨーロッパの網膜色素変性症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの網膜色素変性症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の網膜色素変性症治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの網膜色素変性症治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Astellas Pharma Inc.、Caladrius Biosciences, Inc.、Dompe Farmaceutici S.p.A.、Genable Technologies Limited、Genethon、GenSight Biologics S.A.、Grupo Ferrer Internacional, S.A.、ID Pharma Co., Ltd.、InFlectis BioScience、International Stem Cell Corporation、Ionis Pharmaceuticals, Inc.、M's Science Corporation、Mimetogen Pharmaceuticals Inc.、Nanovector s.r.l.、Orphagen Pharmaceuticals, Inc.
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Retinitis Pigmentosa Treatment Market
The global Retinitis Pigmentosa Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Retinitis Pigmentosa Treatment Scope and Market Size
Retinitis Pigmentosa Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retinitis Pigmentosa Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Astellas Pharma Inc.
Caladrius Biosciences, Inc.
Dompe Farmaceutici S.p.A.
Genable Technologies Limited
Genethon
GenSight Biologics S.A.
Grupo Ferrer Internacional, S.A.
ID Pharma Co., Ltd.
InFlectis BioScience
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
M’s Science Corporation
Mimetogen Pharmaceuticals Inc.
Nanovector s.r.l.
Orphagen Pharmaceuticals, Inc.

Market segment by Type, the product can be split into
BNP-RP
Cenegermin
CPK-850
Cutamesine
FAB-111
Others
Market segment by Application, split into
Hospital
Clinic
Homecare

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinitis Pigmentosa Treatment Revenue
1.4 Market by Type
1.4.1 Global Retinitis Pigmentosa Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 BNP-RP
1.4.3 Cenegermin
1.4.4 CPK-850
1.4.5 Cutamesine
1.4.6 FAB-111
1.4.7 Others
1.5 Market by Application
1.5.1 Global Retinitis Pigmentosa Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Retinitis Pigmentosa Treatment Market Perspective (2015-2026)
2.2 Global Retinitis Pigmentosa Treatment Growth Trends by Regions
2.2.1 Retinitis Pigmentosa Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Retinitis Pigmentosa Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Retinitis Pigmentosa Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Retinitis Pigmentosa Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Retinitis Pigmentosa Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Retinitis Pigmentosa Treatment Players by Market Size
3.1.1 Global Top Retinitis Pigmentosa Treatment Players by Revenue (2015-2020)
3.1.2 Global Retinitis Pigmentosa Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Retinitis Pigmentosa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinitis Pigmentosa Treatment Market Concentration Ratio
3.2.1 Global Retinitis Pigmentosa Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa Treatment Revenue in 2019
3.3 Retinitis Pigmentosa Treatment Key Players Head office and Area Served
3.4 Key Players Retinitis Pigmentosa Treatment Product Solution and Service
3.5 Date of Enter into Retinitis Pigmentosa Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Retinitis Pigmentosa Treatment Historic Market Size by Type (2015-2020)
4.2 Global Retinitis Pigmentosa Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Retinitis Pigmentosa Treatment Market Size by Application (2015-2020)
5.2 Global Retinitis Pigmentosa Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Retinitis Pigmentosa Treatment Market Size (2015-2020)
6.2 Retinitis Pigmentosa Treatment Key Players in North America (2019-2020)
6.3 North America Retinitis Pigmentosa Treatment Market Size by Type (2015-2020)
6.4 North America Retinitis Pigmentosa Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Retinitis Pigmentosa Treatment Market Size (2015-2020)
7.2 Retinitis Pigmentosa Treatment Key Players in Europe (2019-2020)
7.3 Europe Retinitis Pigmentosa Treatment Market Size by Type (2015-2020)
7.4 Europe Retinitis Pigmentosa Treatment Market Size by Application (2015-2020)

8 China
8.1 China Retinitis Pigmentosa Treatment Market Size (2015-2020)
8.2 Retinitis Pigmentosa Treatment Key Players in China (2019-2020)
8.3 China Retinitis Pigmentosa Treatment Market Size by Type (2015-2020)
8.4 China Retinitis Pigmentosa Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Retinitis Pigmentosa Treatment Market Size (2015-2020)
9.2 Retinitis Pigmentosa Treatment Key Players in Japan (2019-2020)
9.3 Japan Retinitis Pigmentosa Treatment Market Size by Type (2015-2020)
9.4 Japan Retinitis Pigmentosa Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Retinitis Pigmentosa Treatment Market Size (2015-2020)
10.2 Retinitis Pigmentosa Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retinitis Pigmentosa Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Retinitis Pigmentosa Treatment Market Size by Application (2015-2020)

11 India
11.1 India Retinitis Pigmentosa Treatment Market Size (2015-2020)
11.2 Retinitis Pigmentosa Treatment Key Players in India (2019-2020)
11.3 India Retinitis Pigmentosa Treatment Market Size by Type (2015-2020)
11.4 India Retinitis Pigmentosa Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Retinitis Pigmentosa Treatment Market Size (2015-2020)
12.2 Retinitis Pigmentosa Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Retinitis Pigmentosa Treatment Market Size by Type (2015-2020)
12.4 Central & South America Retinitis Pigmentosa Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Company Details
13.1.2 Astellas Pharma Inc. Business Overview
13.1.3 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Introduction
13.1.4 Astellas Pharma Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020))
13.1.5 Astellas Pharma Inc. Recent Development
13.2 Caladrius Biosciences, Inc.
13.2.1 Caladrius Biosciences, Inc. Company Details
13.2.2 Caladrius Biosciences, Inc. Business Overview
13.2.3 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Introduction
13.2.4 Caladrius Biosciences, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.2.5 Caladrius Biosciences, Inc. Recent Development
13.3 Dompe Farmaceutici S.p.A.
13.3.1 Dompe Farmaceutici S.p.A. Company Details
13.3.2 Dompe Farmaceutici S.p.A. Business Overview
13.3.3 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Introduction
13.3.4 Dompe Farmaceutici S.p.A. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.3.5 Dompe Farmaceutici S.p.A. Recent Development
13.4 Genable Technologies Limited
13.4.1 Genable Technologies Limited Company Details
13.4.2 Genable Technologies Limited Business Overview
13.4.3 Genable Technologies Limited Retinitis Pigmentosa Treatment Introduction
13.4.4 Genable Technologies Limited Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.4.5 Genable Technologies Limited Recent Development
13.5 Genethon
13.5.1 Genethon Company Details
13.5.2 Genethon Business Overview
13.5.3 Genethon Retinitis Pigmentosa Treatment Introduction
13.5.4 Genethon Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.5.5 Genethon Recent Development
13.6 GenSight Biologics S.A.
13.6.1 GenSight Biologics S.A. Company Details
13.6.2 GenSight Biologics S.A. Business Overview
13.6.3 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Introduction
13.6.4 GenSight Biologics S.A. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.6.5 GenSight Biologics S.A. Recent Development
13.7 Grupo Ferrer Internacional, S.A.
13.7.1 Grupo Ferrer Internacional, S.A. Company Details
13.7.2 Grupo Ferrer Internacional, S.A. Business Overview
13.7.3 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Introduction
13.7.4 Grupo Ferrer Internacional, S.A. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.7.5 Grupo Ferrer Internacional, S.A. Recent Development
13.8 ID Pharma Co., Ltd.
13.8.1 ID Pharma Co., Ltd. Company Details
13.8.2 ID Pharma Co., Ltd. Business Overview
13.8.3 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Introduction
13.8.4 ID Pharma Co., Ltd. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.8.5 ID Pharma Co., Ltd. Recent Development
13.9 InFlectis BioScience
13.9.1 InFlectis BioScience Company Details
13.9.2 InFlectis BioScience Business Overview
13.9.3 InFlectis BioScience Retinitis Pigmentosa Treatment Introduction
13.9.4 InFlectis BioScience Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.9.5 InFlectis BioScience Recent Development
13.10 International Stem Cell Corporation
13.10.1 International Stem Cell Corporation Company Details
13.10.2 International Stem Cell Corporation Business Overview
13.10.3 International Stem Cell Corporation Retinitis Pigmentosa Treatment Introduction
13.10.4 International Stem Cell Corporation Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
13.10.5 International Stem Cell Corporation Recent Development
13.11 Ionis Pharmaceuticals, Inc.
10.11.1 Ionis Pharmaceuticals, Inc. Company Details
10.11.2 Ionis Pharmaceuticals, Inc. Business Overview
10.11.3 Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Introduction
10.11.4 Ionis Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
10.11.5 Ionis Pharmaceuticals, Inc. Recent Development
13.12 M’s Science Corporation
10.12.1 M’s Science Corporation Company Details
10.12.2 M’s Science Corporation Business Overview
10.12.3 M’s Science Corporation Retinitis Pigmentosa Treatment Introduction
10.12.4 M’s Science Corporation Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
10.12.5 M’s Science Corporation Recent Development
13.13 Mimetogen Pharmaceuticals Inc.
10.13.1 Mimetogen Pharmaceuticals Inc. Company Details
10.13.2 Mimetogen Pharmaceuticals Inc. Business Overview
10.13.3 Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Introduction
10.13.4 Mimetogen Pharmaceuticals Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
10.13.5 Mimetogen Pharmaceuticals Inc. Recent Development
13.14 Nanovector s.r.l.
10.14.1 Nanovector s.r.l. Company Details
10.14.2 Nanovector s.r.l. Business Overview
10.14.3 Nanovector s.r.l. Retinitis Pigmentosa Treatment Introduction
10.14.4 Nanovector s.r.l. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
10.14.5 Nanovector s.r.l. Recent Development
13.15 Orphagen Pharmaceuticals, Inc.
10.15.1 Orphagen Pharmaceuticals, Inc. Company Details
10.15.2 Orphagen Pharmaceuticals, Inc. Business Overview
10.15.3 Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Introduction
10.15.4 Orphagen Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020)
10.15.5 Orphagen Pharmaceuticals, Inc. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Retinitis Pigmentosa Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Retinitis Pigmentosa Treatment Revenue
Table 3. Ranking of Global Top Retinitis Pigmentosa Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinitis Pigmentosa Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of BNP-RP
Table 6. Key Players of Cenegermin
Table 7. Key Players of CPK-850
Table 8. Key Players of Cutamesine
Table 9. Key Players of FAB-111
Table 10. Key Players of Others
Table 11. Global Retinitis Pigmentosa Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Retinitis Pigmentosa Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Retinitis Pigmentosa Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Retinitis Pigmentosa Treatment Market Share by Regions (2015-2020)
Table 15. Global Retinitis Pigmentosa Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Retinitis Pigmentosa Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Retinitis Pigmentosa Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Retinitis Pigmentosa Treatment Players
Table 22. Global Retinitis Pigmentosa Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Retinitis Pigmentosa Treatment Market Share by Players (2015-2020)
Table 24. Global Top Retinitis Pigmentosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinitis Pigmentosa Treatment as of 2019)
Table 25. Global Retinitis Pigmentosa Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Retinitis Pigmentosa Treatment Product Solution and Service
Table 28. Date of Enter into Retinitis Pigmentosa Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Retinitis Pigmentosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Retinitis Pigmentosa Treatment Market Size Share by Type (2015-2020)
Table 32. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Retinitis Pigmentosa Treatment Market Size Share by Application (2015-2020)
Table 34. Global Retinitis Pigmentosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Retinitis Pigmentosa Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Retinitis Pigmentosa Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Retinitis Pigmentosa Treatment Market Share (2019-2020)
Table 38. North America Retinitis Pigmentosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Retinitis Pigmentosa Treatment Market Share by Type (2015-2020)
Table 40. North America Retinitis Pigmentosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Retinitis Pigmentosa Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Retinitis Pigmentosa Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Retinitis Pigmentosa Treatment Market Share (2019-2020)
Table 44. Europe Retinitis Pigmentosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Retinitis Pigmentosa Treatment Market Share by Type (2015-2020)
Table 46. Europe Retinitis Pigmentosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Retinitis Pigmentosa Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Retinitis Pigmentosa Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Retinitis Pigmentosa Treatment Market Share (2019-2020)
Table 50. China Retinitis Pigmentosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Retinitis Pigmentosa Treatment Market Share by Type (2015-2020)
Table 52. China Retinitis Pigmentosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Retinitis Pigmentosa Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Retinitis Pigmentosa Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Retinitis Pigmentosa Treatment Market Share (2019-2020)
Table 56. Japan Retinitis Pigmentosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Retinitis Pigmentosa Treatment Market Share by Type (2015-2020)
Table 58. Japan Retinitis Pigmentosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Retinitis Pigmentosa Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Retinitis Pigmentosa Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Retinitis Pigmentosa Treatment Market Share (2019-2020)
Table 62. Southeast Asia Retinitis Pigmentosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Retinitis Pigmentosa Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Retinitis Pigmentosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Retinitis Pigmentosa Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Retinitis Pigmentosa Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Retinitis Pigmentosa Treatment Market Share (2019-2020)
Table 68. India Retinitis Pigmentosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Retinitis Pigmentosa Treatment Market Share by Type (2015-2020)
Table 70. India Retinitis Pigmentosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Retinitis Pigmentosa Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Retinitis Pigmentosa Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Retinitis Pigmentosa Treatment Market Share (2019-2020)
Table 74. Central & South America Retinitis Pigmentosa Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Retinitis Pigmentosa Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Retinitis Pigmentosa Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Retinitis Pigmentosa Treatment Market Share by Application (2015-2020)
Table 78. Astellas Pharma Inc. Company Details
Table 79. Astellas Pharma Inc. Business Overview
Table 80. Astellas Pharma Inc. Product
Table 81. Astellas Pharma Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 82. Astellas Pharma Inc. Recent Development
Table 83. Caladrius Biosciences, Inc. Company Details
Table 84. Caladrius Biosciences, Inc. Business Overview
Table 85. Caladrius Biosciences, Inc. Product
Table 86. Caladrius Biosciences, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 87. Caladrius Biosciences, Inc. Recent Development
Table 88. Dompe Farmaceutici S.p.A. Company Details
Table 89. Dompe Farmaceutici S.p.A. Business Overview
Table 90. Dompe Farmaceutici S.p.A. Product
Table 91. Dompe Farmaceutici S.p.A. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 92. Dompe Farmaceutici S.p.A. Recent Development
Table 93. Genable Technologies Limited Company Details
Table 94. Genable Technologies Limited Business Overview
Table 95. Genable Technologies Limited Product
Table 96. Genable Technologies Limited Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 97. Genable Technologies Limited Recent Development
Table 98. Genethon Company Details
Table 99. Genethon Business Overview
Table 100. Genethon Product
Table 101. Genethon Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 102. Genethon Recent Development
Table 103. GenSight Biologics S.A. Company Details
Table 104. GenSight Biologics S.A. Business Overview
Table 105. GenSight Biologics S.A. Product
Table 106. GenSight Biologics S.A. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 107. GenSight Biologics S.A. Recent Development
Table 108. Grupo Ferrer Internacional, S.A. Company Details
Table 109. Grupo Ferrer Internacional, S.A. Business Overview
Table 110. Grupo Ferrer Internacional, S.A. Product
Table 111. Grupo Ferrer Internacional, S.A. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 112. Grupo Ferrer Internacional, S.A. Recent Development
Table 113. ID Pharma Co., Ltd. Business Overview
Table 114. ID Pharma Co., Ltd. Product
Table 115. ID Pharma Co., Ltd. Company Details
Table 116. ID Pharma Co., Ltd. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 117. ID Pharma Co., Ltd. Recent Development
Table 118. InFlectis BioScience Company Details
Table 119. InFlectis BioScience Business Overview
Table 120. InFlectis BioScience Product
Table 121. InFlectis BioScience Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 122. InFlectis BioScience Recent Development
Table 123. International Stem Cell Corporation Company Details
Table 124. International Stem Cell Corporation Business Overview
Table 125. International Stem Cell Corporation Product
Table 126. International Stem Cell Corporation Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 127. International Stem Cell Corporation Recent Development
Table 128. Ionis Pharmaceuticals, Inc. Company Details
Table 129. Ionis Pharmaceuticals, Inc. Business Overview
Table 130. Ionis Pharmaceuticals, Inc. Product
Table 131. Ionis Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 132. Ionis Pharmaceuticals, Inc. Recent Development
Table 133. M's Science Corporation Company Details
Table 134. M's Science Corporation Business Overview
Table 135. M's Science Corporation Product
Table 136. M's Science Corporation Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 137. M's Science Corporation Recent Development
Table 138. Mimetogen Pharmaceuticals Inc. Company Details
Table 139. Mimetogen Pharmaceuticals Inc. Business Overview
Table 140. Mimetogen Pharmaceuticals Inc. Product
Table 141. Mimetogen Pharmaceuticals Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 142. Mimetogen Pharmaceuticals Inc. Recent Development
Table 143. Nanovector s.r.l. Company Details
Table 144. Nanovector s.r.l. Business Overview
Table 145. Nanovector s.r.l. Product
Table 146. Nanovector s.r.l. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 147. Nanovector s.r.l. Recent Development
Table 148. Orphagen Pharmaceuticals, Inc. Company Details
Table 149. Orphagen Pharmaceuticals, Inc. Business Overview
Table 150. Orphagen Pharmaceuticals, Inc. Product
Table 151. Orphagen Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2015-2020) (Million US$)
Table 152. Orphagen Pharmaceuticals, Inc. Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinitis Pigmentosa Treatment Market Share by Type: 2020 VS 2026
Figure 2. BNP-RP Features
Figure 3. Cenegermin Features
Figure 4. CPK-850 Features
Figure 5. Cutamesine Features
Figure 6. FAB-111 Features
Figure 7. Others Features
Figure 8. Global Retinitis Pigmentosa Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Homecare Case Studies
Figure 12. Retinitis Pigmentosa Treatment Report Years Considered
Figure 13. Global Retinitis Pigmentosa Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Retinitis Pigmentosa Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Retinitis Pigmentosa Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Retinitis Pigmentosa Treatment Market Share by Players in 2019
Figure 18. Global Top Retinitis Pigmentosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinitis Pigmentosa Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa Treatment Revenue in 2019
Figure 20. North America Retinitis Pigmentosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Retinitis Pigmentosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Retinitis Pigmentosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Retinitis Pigmentosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Retinitis Pigmentosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Retinitis Pigmentosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Retinitis Pigmentosa Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介

網膜色素変性症治療・管理の世界市場（～2026年）

Global Retinitis Pigmentosa Treatment & Management Market Size, Status and Forecast 2020-2026
MRC2-11QY04503 2020年11月20日 94Pages
当調査資料は網膜色素変性症治療・管理のグローバル市場について調査・分析したレポートです。種類別（ビタミンA、ドコサヘキサエン酸、カルシウムチャネル遮断薬、遺伝子治療、義眼）市場規模、用途別（病院、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

サイトメガロウイルス（CMV）網膜炎治療の世界市場（～2026年）

Global Cytomegalovirus Retinitis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11555 2020年11月25日 93Pages
当調査資料はサイトメガロウイルス（CMV）網膜炎治療のグローバル市場について調査・分析したレポートです。種類別（カプセル、溶液、インプラント、錠剤）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

脂質異常症治療の世界市場（～2026年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12520 2020年11月25日 92Pages
当調査資料は脂質異常症治療のグローバル市場について調査・分析したレポートです。種類別（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

水疱性類天疱瘡治療の世界市場（～2026年）

Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11210 2020年11月25日 91Pages
当調査資料は水疱性類天疱瘡治療のグローバル市場について調査・分析したレポートです。種類別（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）市場規模、用途別（病院薬局、小売薬局、通信販売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...

ナルコレプシー治療の世界市場（～2026年）

Global Narcolepsy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03907 2020年11月20日 94Pages
当調査資料はナルコレプシー治療のグローバル市場について調査・分析したレポートです。種類別（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）市場規模、用途別（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー）市場規模、...

ジフテリア治療の世界市場（～2026年）

Global Diphtheria Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11675 2020年11月25日 97Pages
当調査資料はジフテリア治療のグローバル市場について調査・分析したレポートです。種類別（破傷風免疫グロブリン、破傷風トキソイド、破傷風-ジフテリア、ジフテリアトキソイド、百日咳）市場規模、用途別（抗毒素、抗生物質、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

消化器疾患治療　の世界市場（～2026年）

Global Digestive Distress Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11647 2020年11月25日 96Pages
当調査資料は消化器疾患治療　のグローバル市場について調査・分析したレポートです。種類別（上部消化管、下部消化管）市場規模、用途別（病院薬局、オンライン薬局、ドラッグストア、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

ハンセン病治療の世界市場（～2026年）

Global Leprosy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12500 2020年11月25日 93Pages
当調査資料はハンセン病治療のグローバル市場について調査・分析したレポートです。種類別（スルホン、フェナジン誘導体、抗管状薬、その他）市場規模、用途別（病院、クリニック、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

軟骨肉腫治療の世界市場（～2026年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11355 2020年11月25日 96Pages
当調査資料は軟骨肉腫治療のグローバル市場について調査・分析したレポートです。種類別（外科的治療、化学療法、放射線療法）市場規模、用途別（病院、専門クリニック、がん治療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

肝疾患治療の世界市場（～2026年）

Global Liver Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12531 2020年11月25日 94Pages
当調査資料は肝疾患治療のグローバル市場について調査・分析したレポートです。種類別（肝臓有毒傷害、感染性病原体・寄生虫、免疫障害、腫瘍、遺伝性肝疾患）市場規模、用途別（病院、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

網膜色素変性症治療・管理の世界市場（～2026年） Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision. Retinitis pigmentosa is generally inherited from a person's parents. Mutations in one of more than 50 genes is involved. Market Analysis and Insights: Global Retinitis Pigmentosa Treatment & Management Market The…
サイトメガロウイルス（CMV）網膜炎治療の世界市場（～2026年） Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related …
気管支拡張症治療の世界市場（～2026年） Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in seri…
統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…
巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …